Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Debulking strategies before cellular therapy
Rogers favors BTK inhibitors and venetoclax for bridging to CAR‑T, avoiding lymphotoxic chemo when possible to preserve T cells.
Play episode from 42:29
Transcript
